Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases

Objective Evaluate spondyloarthritis (SpA) incidence in inflammatory bowel diseases (IBD) between patients treated with biological disease-modifying antirheumatic drugs (bDMARDs) and conventional DMARDs (cDMARDs) and define risk factors associated with SpA development.Methods Retrospective cohort st...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Paola Conigliaro, Maria Sole Chimenti, Paola Triggianese, Alberto Bergamini, Mauro Fatica, Benedetta Monosi, Arianna D’Antonio, Sara Essofi, Elisa Cuccagna, Livia Biancone, Giovanni Monteleone, Emma Calabrese
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2024-02-01
coleção:	RMD Open
Acesso em linha:	https://rmdopen.bmj.com/content/10/1/e003820.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!